Omalizumab treatment in brittle asthma

Postepy Dermatologii i Alergologii

Volumn 31, Issue 1, 2014, Pages 36-38

  Skiepko, Roman ^a   Zietkowski, Ziemowit ^a   Skiepko, Urszula ^a   Budny, Wojciech ^a   Lukaszyk, Mateusz ^a   Bodzenta Lukaszyk, Anna ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Brittle asthma; Omalizumab

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CICLESONIDE; FLUTICASONE; IMMUNOGLOBULIN E; MONTELUKAST; OMALIZUMAB;

ADULT; ALLERGIC ASTHMA; ARTICLE; BRITTLE ASTHMA; CASE REPORT; CONSCIOUSNESS DISORDER; CYANOSIS; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; GLASGOW COMA SCALE; HEART MURMUR; HUMAN; LUNG FUNCTION TEST; MAINTENANCE THERAPY; MIDDLE AGED; OUTCOME ASSESSMENT; PAROXYSMAL DYSPNEA; PEAK EXPIRATORY FLOW; PHYSICAL EXAMINATION; PRICK TEST; TACHYCARDIA; TREATMENT DURATION;

EID: 84896799499     PISSN: 1642395X     EISSN: None     Source Type: Journal    
DOI: 10.5114/pdia.2014.40658     Document Type: Article

References (10)

1. Ayres JG, Miles JF, Barnes PJ. Brittle asthma. Thorax 1998; 53: 315-21. (Pubitemid 28215795)
2. Ayres JG, Thompson RA. IgG sub-class deficiency in brittle asthma and in patients with recurrent infective exacerbations of asthma. Respir Med 1997; 91: 464-9. (Pubitemid 27359138)
3. Miles JF, Cayton RM, Tunniclife WS, et al. Increased atopic sensitization in brittle asthma. Clin Exp Allergy 1995; 25: 1074-82.
4. Miles JF, Cayton RM, Tunnicliffe WS, Ayres JG. Increased atopic sensitization in brittle asthma. Clin Exp Allergy 1995; 25: 1074-82.
5. Hanf G, Brachmann I, Kleine-Tebbe J, et al. Omalizumab decreased IgE-release and induced changes in cellular immunity in patients with allergic asthma. Allergy 2006; 61: 1141-4. (Pubitemid 44175224)
6. Platts-Mills TA. The role of immunoglobulin E in allergy and asthma. Am J Respir Crit Care Med 2001; 164: 1-5.
7. Noga O, Hanf G, Kunkel G. Immunological and clinical changes in allergic asthmatics following treatment with omalizumab. Int Arch Allergy Immunol 2003; 131: 46-52. (Pubitemid 36649357)
8. Zietkowski Z, Skiepko R, Tomasiak-Lozowska MM, et al. RANTES in exhaled breath condensate of patients with severe persistent allergic asthma during omalizumab therapy. Int Arch Allergy Immunol 2011; 154: 25-32.
9. Zietkowski Z, Skiepko R, Tomasiak-Lozowska MM, Bodzenta-Lukaszyk A. Anti-IgE therapy with omalizumab decreases endothelin-1 in exhaled breath condensate of patients with severe persistent allergic asthma. Respiration 2010; 80: 534-42.
10. Ayres JG, Jyothish D, Ninan T. Brittle asthma. Paediatr Respir Rev 2004; 5: 40-4. (Pubitemid 38256164)